IL22RA1 and colitis: IL-22ra1 expression was detected mainly in goblet cells and enterocytes for both treated and disease controls at similar levels, but interestingly it was noted that I3C treatment increased expression of this receptor component in fibroblasts, which was not present in colitis controls (Supplementary Figure 2).